mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
mTORC1 is a key mediator of drug resistance and also regulates autophagy. In this study, the authors demonstrate that cancer cells with acquired drug resistance exibit metabolic vulnerabilities mediated by high levels of mTORC1 and the consequent inhibition of autophagy.
Guardado en:
Autores principales: | Niklas Gremke, Pierfrancesco Polo, Aaron Dort, Jean Schneikert, Sabrina Elmshäuser, Corinna Brehm, Ursula Klingmüller, Anna Schmitt, Hans Christian Reinhardt, Oleg Timofeev, Michael Wanzel, Thorsten Stiewe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9653fbfc87624dd8b531af0c6eab20e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
mTOR controls ovarian follicle growth by regulating granulosa cell proliferation.
por: James Yu, et al.
Publicado: (2011) -
Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway
por: Xiangjin Zheng, et al.
Publicado: (2021) -
Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma.
por: Xiaoqi Xie, et al.
Publicado: (2013) -
L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation
por: Beatriz Castejón-Vega, et al.
Publicado: (2021) -
Yu Nu Compound Regulates Autophagy and Apoptosis Through mTOR in vivo and vitro
por: He C, et al.
Publicado: (2020)